LEN vs MRP: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: MRP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. LEN and MRP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined LEN and MRP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Lennar is one of the largest homebuilders in the United States, building and selling new single-family homes, townhomes, and some multifamily communities across many states. The company operates an integrated model: it acquires and develops land, constructs homes, and provides related financial services through Lennar Financial Services, which offers mortgage origination, title, and closing services to its buyers. Lennar has pushed an asset-light, land-light strategy, shifting toward optioning land and using third-party land banks rather than owning large inventories of raw land outright, which reduces capital tied up and improves returns. It also spun off some land-holding assets into a separate entity to sharpen this focus. Lennar makes money on the spread between home sales prices and the cost of land and construction, plus fees from its mortgage and title operations and its multifamily and technology investments. Demand is driven by household formation, employment, and mortgage rates. The company is highly sensitive to interest rates and the housing cycle. Headquartered in Miami, Florida, Lennar is a long-standing leader in US residential construction.

Full LEN guide

Millrose Properties, Inc. (NYSE: MRP) was spun off from Lennar in February 2025 and operates what it calls a homesite option platform. The company acquires residential land, funds its horizontal development, and holds it on its own balance sheet while a homebuilder pays a monthly cash option fee on the capital deployed. When the builder needs finished lots, it exercises the option and buys them at a predetermined price, returning cash to Millrose to redeploy. As of June 30, 2026, the portfolio covered 143,771 homesites across 877 communities in 30 states, carried at ~$9.6 billion of homesites under option contracts, earning a weighted average annualized yield of ~9.2%. Millrose has no employees: it is externally managed by Kennedy Lewis Land and Residential Advisors LLC, a subsidiary of Kennedy Lewis Investment Management, for a fee of 1.25% of tangible assets.

Full MRP guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• LEN drivers: Structural US housing shortage; Asset-light, land-light strategy.
• MRP drivers: Diversification away from Lennar; Builders converting land ownership into an operating expense.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Lennar is highly cyclical and acutely sensitive to mortgage rates: when rates rise, affordability falls, demand softens, and Lennar often resorts to price cuts and mortgage-rate buydowns that compress margins. For MRP, counterparty concentration is the defining exposure: Lennar homesites under option contracts were ~$6.4 billion of the ~$9.6 billion portfolio at June 30, 2026, so a slowdown in Lennar's takedown pace would show up quickly in option fees and recycling.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick LEN if you believe its drivers more; MRP if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the LEN and MRP guides.

LEN. Lennar trades at a low single-digit-to-low-double-digit earnings multiple, typical of cyclical homebuilders that the market values cautiously because profits swing with the housing cycle. The low multiple reflects sensitivity to mortgage rates and recession risk, partly offset by Lennar's scale, strong balance sheet, and land-light strategy. The valuation is also often viewed against book value, which tends to be a steadier anchor than peak-cycle earnings.

MRP. All figures are in US dollars, taken from the Form 10-Q for the quarter ended June 30, 2026 and the Form 10-K for 2025. Trailing twelve month revenue of ~$761 million spans the four quarters through June 2026 and is fully standalone; the stub 2025 periods before that reflect a company that only began trading in February 2025. With ~166 million Class A and Class B shares outstanding against stockholders' equity of ~$5.85 billion, book value works out near ~$35 per share, so a share price around ~$29 implies roughly ~0.82 times book alongside a double-digit distribution yield.

Headline figures (approximate, early 2026): LEN shows revenue (ttm) ~$35 billion, operating margin ~12%, net income (ttm) ~$3-4 billion, p/e (ttm) ~11x (low, reflecting cyclicality); MRP shows revenue (ttm) ~$761M, net income (ttm) ~$476M, diluted eps (ttm) ~$2.87, market cap ~$4.9B.

LEN and MRP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined LEN and MRP exposure against your real portfolio. It is not an investment adviser.